Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?

by Tri Le, David E. Gerber
Published 2019-03-01

Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients?

by Mitchell S. von Itzstein, David E. Gerber, John D. Minna
Published 2020-10-01

How have we diagnosed early-stage lung cancer without radiographic screening? A contemporary single-center experience.

by Evelyn O Taiwo, Jeffrey T Yorio, Jingsheng Yan, David E Gerber
Published 2012-01-01

Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care qualit...

by Mitchell S von Itzstein, Arjun Gupta, Kemp H Kernstine, Kristin C Mara, Sahil Khanna, David E Gerber
Published 2020-01-01

Thirteen-Year Survival in a Patient With Diffuse Bilateral Lepidic-Predominant Adenocarcinoma: A Case Report of Lung Transplantation and Local Salvage

by Elizabeth R. Zhang-Velten, MD, PhD, David E. Gerber, MD, Kenneth D. Westover, MD, PhD
Published 2020-11-01

Closing the gap: Contribution of surgical best practices to outcome differences between high‐ and low‐volume centers for lung cancer resection

by Mitchell S. vonItzstein, Rong Lu, Kemp H. Kernstine, Ethan A. Halm, Shidan Wang, Yang Xie, David E. Gerber
Published 2020-06-01

DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden

by David Hsiehchen, Antony Hsieh, Robert M. Samstein, Tianshi Lu, Muhammad S. Beg, David E. Gerber, Tao Wang, Luc G.T. Morris, Hao Zhu
Published 2020-06-01

Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer

by Shetal A. Patel, David E. Gerber, Allison Deal, Kathe Douglas, Chad V. Pecot, Carrie Lee, Joan Schiller, Nirav Dhruva, Jared Weiss
Published 2021-04-01

Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG‐ACRIN E2805 trial

by Caitlin C. Murphy, Hannah M. Fullington, David E. Gerber, Isaac Alex Bowman, Maneka Puligandla, Janice P. Dutcher, Robert S. DiPaola, Naomi B. Haas
Published 2021-09-01

Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer

by Sandi L. Pruitt, David E. Gerber, Hong Zhu, Daniel F. Heitjan, Bhumika Maddineni, Danyi Xiong, Amit G. Singal, Anna Tavakkoli, Ethan A. Halm, Caitlin C. Murphy
Published 2021-07-01

A randomized trial of mail and email recruitment strategies for a physician survey on clinical trial accrual

by Caitlin C. Murphy, Simon J. Craddock Lee, Ann M. Geiger, John V. Cox, Chul Ahn, Rasmi Nair, David E. Gerber, Ethan A. Halm, Katharine McCallister, Celette Sugg Skinner
Published 2020-05-01

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

by Tao Wang, Rong Lu, Sunny Lai, Joan H Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E Gerber, David H Johnson, Guanghua Xiao, Yang Xie
Published 2019-04-01

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy

by Osama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, Andrew Leiker, Alana Christie, Elizabeth Zhang-Velten, Lakshya Trivedi, Saad Khan, Neil B Desai, Aaron Laine, Kevin Albuquerque, Puneeth Iyengar, Yull Arriaga, Kevin Courtney, David E. Gerber, Hans Hammers, Hak Choy, Robert Timmerman, James Brugarolas, Raquibul Hannan
Published 2018-07-01

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

by Rajeev Sharma, Laura C Cappelli, Michelle Turner, Julie R Brahmer, Paolo Antonio Ascierto, Hamzah Abu-Sbeih, Jeffrey A Sosman, Jill Brufsky, Mario E Lacouture, Lamya Hamad, Miguel-Angel Perales, Eric Hansen, David E Gerber, Frank B Cortazar, Gregory A Masters, Michele Nanni, Satish P Shanbhag, Dimitra Skondra
Published 2021-06-01